IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Liminal Biosciences Inc

CUSIP: 53272L202 | 9 institutional holders

Quarters

Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

National Bank of Canada9,852
0.0% of portfolio›$61.1K
Federation des caisses Desjardins du Quebec3,377
0.0% of portfolio›$21.2K
Morgan Stanley1,706
0.0% of portfolio›$10.7K
Royal Bank of Canada1,039
0.0% of portfolio›$7.0K
UBS Group AG715
0.0% of portfolio›$4.5K
Estabrook Capital Management500
0.0% of portfolio›$3.1K
TD Waterhouse Canada Inc.3
0.0% of portfolio›$25
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
National Bank of Canada
9,852$61.1K0.0%CoreMediumMontreal, Austria2023-07-26
Federation des caisses Desjardins du Quebec
3,377$21.2K0.0%ValueMediumLevis, Austria2024-08-15
Morgan Stanley
1,706$10.7K0.0%CoreLowNew York, NY2023-08-14
Royal Bank of Canada
1,039$7.0K0.0%CoreLowToronto, Australia2023-08-14
UBS Group AG
715$4.5K0.0%CoreMediumZurich, Switzerland2023-08-11
Estabrook Capital Management
500$3.1K0.0%CoreVery LowNew York, NY2023-08-11
TD Waterhouse Canada Inc.
3$250.0%CoreLowToronto, Australia2023-11-13
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-08-10